Clinical trial Recruiting at 2 sites Observational Ages 50 to 75

Mobile low-dose CT lung cancer screening program

Official title: Lyon Initiative for the Mobile Demedicalized Initiation of Lung Cancer Screening

Run by Hospices Civils de Lyon · NCT07015151 · Data updated 2026-11-12

This project will try using a CT-equipped mobile unit versus a hospital screening unit to screen people aged 50–74 with a heavy smoking history.

Quick facts

Study typeObservational
Ages50 Years to 75 Years
SexAll
Enrollment4312 (estimated)
SponsorHospices Civils de Lyon
Academic / other
Locations2 sites (Pierre-Bénite and 1 other locations)
StatusRecruiting
StartedJune 12, 2025
Main results expectedSeptember 2028
Study endsSeptember 2028
Registry record updatedSeptember 9, 2025
Trial IDNCT07015151 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

People aged 50–74 who are current smokers or who quit within the past 15 years with a substantial smoking history (roughly ≥20 pack-years or equivalent by specified conversion), covered by French social security, and able to provide informed consent.

Probably not a fit

People outside the age or smoking-history eligibility criteria or those with severe comorbidities that preclude LDCT or follow-up care are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

MobILYAD compares a demedicalized CT-equipped mobile van staffed by trained nurses with a conventional hospital-based screening pathway at Hôpital Lyon Sud to determine which better reaches socially disadvantaged populations. Eligible participants receive low-dose chest CT, spirometry, a cardiovascular risk check, smoking cessation support, and optional biospecimen collection. The project uses a proactive 'reach-out' strategy informed by mobile screening models from other countries and by mobile mammography experience in France. Results will inform the national pilot program (IMPULSION) planned for 2025 by measuring participation, detection rates, and operational feasibility.

Why it matters

Potential benefit: If successful, the mobile approach could increase screening uptake among underserved populations and help detect lung cancers earlier in high-risk smokers.

How similar studies have gone: Mobile outreach screening approaches have shown effectiveness in the UK, Brazil, and the USA and mobile mammography has been used in France, supporting the rationale though mobile LDCT in France is being newly tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria \* :

* Persons aged over 50 and under 75 (74 years of age or older).
* Active smokers or former smokers who quit less than 15 years ago.
* Persons whose consumption is estimated at 20 packs/year or more, down to ≥15 cigarettes/day for a duration of consumption of ≥25 years and up to ≥10 cigarettes/day for ≥30 years, which takes into account the predominance of duration of consumption over quantity consumed in the risk of lung cancer. A pack-year corresponds to the consumption of one pack of 20 manufactured cigarettes per day for one year. A multiplier coefficient will be taken into account depending on the mode of consumption: Rolled cigarettes: 2; Cigarillos: 3; Cigars: 4; Pipes: 2.5; Hookahs: 25.
* Persons affiliated with social security. - Person having signed their consent to participate in the study after having received full information about it, including the risks associated with participation.

  * Exclusion Criteria \* :
* Individuals with severe comorbidities contraindicating lung cancer investigations and/or treatment (including surgery or stereotactic radiotherapy);
* Individuals with impaired general condition (PS 2 and above);
* Individuals with dyspnea at rest (mMRC4);
* Individuals with a history of cancer undergoing active surveillance by chest computed tomography (CT or PET scan); personal history of lung cancer (lifetime);
* Individuals with symptoms suggestive of lung cancer (hemoptysis, unexplained weight loss, recent onset or change in respiratory symptoms, etc.);
* Individuals refusing to participate in the study
* Individuals withdrawing their consent.

Where it's running

  • " Centre de dépistage mobile " - Hôpital Lyon Sud
    Pierre-Bénite, France
    Recruiting
  • Service de Pneumologie " Centre de dépistage non mobile " - Hôpital Lyon Sud
    Pierre-Bénite, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.